Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 12 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 9/21/2007


1.		Phase III Randomized Comparison of the Influence of Chemoprevention with Vitamin A and/or N-Acetylcysteine vs No Treatment on Development and Detection of Second Primary Cancers in Patients Curatively Treated for Laryngeal, Oral Cavity, and Nonsmall Cell Lung Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				75 and under								EORTC-08871 EORTC-24871

Last Modified: 5/1/1998 First Published: 11/1/1997


2.		Phase II Chemoprevention of Head and Neck Cancer by Acetylcysteine (Summary Last Modified 05/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Completed				Over 18				NCI				GUMC-19196 NCI-P97-0118

Last Modified: 12/18/2002 First Published: 7/1/1998


3.		Phase I/II Study of High-Dose Acetaminophen With Carmustine in Patients With Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Over 18				NCI				MSKCC-97124 NCI-H98-0014, NCT00003346


4.		Phase II Chemotherapy with Ifosfamide plus N-Acetylcysteine in Patients with Metastatic Adenocarcinoma of the Pancreas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAOP-5483


5.		Phase II Combination Chemotherapy with VIP (VP-16/IPP/CACP) for Refractory Hodgkin's and non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				CTEPIS-0215 NCI-T83-1118D


6.		Phase II Chemotherapy with ADR plus Cardioprotective Therapy with N-Acetylcysteine for Breast Cancer, Soft Tissue Sarcoma, and Nodular Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				no age specified								NCI-78-C-152


7.		Pilot Phase II Chemotherapy with IPP plus N-Acetylcysteine for Refractory Testicular Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-D82-067-825


8.		Phase II Chemotherapy with Ifosfamide Alone or in Combination with Other Chemotherapeutic Agents for Refractory Testicular Cancer and Extra-gonadal and Ovarian Germ Cell Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								IUMC-830226 NCI-C83-0725


9.		Phase II Chemotherapy with Ifosfamide for Advanced Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								SEG-LUN-82284


10.		Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				20 to 80				Other				whilde157/2003 NCT00196885

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute